How many insider declarations does 复星医药 have?

复星医药 has filed 3 insider declarations with AMF.

Who is the top reporting insider at 复星医药?

The top reporting insider at 复星医药 is 董晓娴, based on the count of public filings.

What is the net insider buy vs sell volume on 复星医药?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

复星医药: insider trades · France · AMF

SSE:600196FR·AMFMcap 65.8Bn€

AMF ↗

Discover the full management transaction log of 复星医药, a listed equity based in France. Shares are quoted on FR FR, under the oversight of AMF. Market capitalisation: €65.8bn. The latest transaction was disclosed on 13 September 2022 — Purchase. Among the most active insiders: 董晓娴. The full history is openly available.

3

Insider Decl.

0

Thresholds

·

2 ops.

Buy Volume

·

1 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

24.06 €

Income statement

Revenue41.66 Bn€

Gross profit20.86 Bn€50% margin

Net income3.37 Bn€8.1% margin

Balance sheet & cash

Market cap65.82 Bn€

Total debt38.09 Bn€

Free Cash Flow764.8 M€

Last declaration on 13 September 2022

All Executives3 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations